EUVIMEDOpdag EUVIMED
Crossref

Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup

Sara Massironi iD, Marco Vincenzo Lenti iD, Edith Lahner iD, Maria Galbiati, Flavia Scatena, Emanuela Miceli, Chiara Della Bella iD, Federica Facciotti iD, Mario M D'Elios, Antonio Di Sabatino iD, Silvio Danese iD, Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO)

Alimentary Pharmacology & Therapeutics · 2026-11 · 64 (10) · 1421-1431

DOI: 10.1111/apt.70954 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, published online on 2026-09-06. Written by Sara Massironi and 11 co-authors. Institution: School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy. Major MEDLINE topics: Proton Pump Inhibitors, Stomach Neoplasms, Autoimmune Diseases, Neuroendocrine Tumors. Cited 9 times so far (Crossref); 54 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Aims Autoimmune gastritis (AIG) is characterized by chronic hypergastrinemia and is associated with an increased risk of gastric neuroendocrine neoplasms (gNENs). Because proton pump inhibitors (PPIs) further increase gastrin secretion, concerns have been raised regarding a potential additive effect on gastric neoplastic risk. This study aimed to evaluate the association between PPI exposure and gNEN occurrence in patients with AIG using a large real‐world database.

Methods

We conducted a retrospective propensity score‐matched cohort study using the TriNetX Global Collaborative Network. Patients with AIG were identified using diagnostic codes for chronic atrophic gastritis or pernicious anaemia, excluding Helicobacter pylori infection, gastric cancer, multiple endocrine neoplasia or other competing gastric conditions. Two cohorts were defined: patients with AIG receiving PPIs and patients without PPI exposure. The primary outcome was the overall occurrence of gNENs. A prespecified secondary analysis excluded patients with gNENs diagnosed before the index date to evaluate incident tumours. Secondary outcomes included hypergastrinemia, intestinal metaplasia and gastric polyps.

Results

A total of 153,687 patients with AIG were identified. After 1:1 propensity score matching, 40,489 patients were included in each cohort. After propensity score matching, gNENs were recorded in 241 patients (0.60%) without PPI exposure and 360 patients (0.89%) receiving PPIs. PPI exposure was associated with a significantly higher occurrence of gNENs (risk ratio [RR] 1.49, 95% CI 1.27–1.76), which was confirmed by time‐to‐event analysis (hazard ratio [HR] 1.44, 95% CI 1.22–1.70; log‐rank p < 0.001). The association persisted after exclusion of patients with pre‐existing gNENs (RR 1.61, 95% CI 1.26–2.06; HR 1.52, 95% CI 1.19–1.95). PPI exposure was also associated with higher occurrences of hypergastrinemia (HR 1.17, 95% CI 1.00–1.37), intestinal metaplasia (HR 1.53, 95% CI 1.36–1.71) and gastric polyps (HR 2.48, 95% CI 2.25–2.73). No gastric adenocarcinomas were identified during follow‐up.

Conclusions

In this large real‐world propensity score‐matched study, PPI exposure was associated with a greater occurrence of both overall and incident gNENs in patients with AIG. PPI use was also consistently associated with gastric mucosal alterations, including hypergastrinemia, intestinal metaplasia and gastric polyps. Although the absolute risk of gNENs remained low, these findings support judicious long‐term PPI prescribing in patients with AIG and reinforce the importance of appropriate endoscopic surveillance in this high‐risk population.

Subjects

MeSH terms (MEDLINE)

Proton Pump InhibitorsStomach NeoplasmsAutoimmune DiseasesNeuroendocrine TumorsGastritisHumansFemaleMalePropensity ScoreMiddle AgedRetrospective StudiesAgedItalyAdultGastrinsRisk FactorsGastritis, Atrophic

Author keywords

autoimmune gastritisgastric neuroendocrine neoplasmsgastric polypshypergastrinemiaintestinal metaplasiaproton pump inhibitors

Substances

Proton Pump InhibitorsGastrins

Authors and institutions

  • School of Medicine and Surgery, Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy.
  • First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Department of Surgical-Medical Sciences and Translational Medicine, Digestive and Liver Disease Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Gastroenterology and Endoscopy Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

ORCID profiles: Sara Massironi, Marco Vincenzo Lenti, Edith Lahner, Chiara Della Bella, Federica Facciotti, Antonio Di Sabatino, Silvio Danese

Cite

APA

Massironi, S., Lenti, M. V., Lahner, E., Galbiati, M., Scatena, F., Miceli, E., Bella, C. D., Facciotti, F., D'Elios, M. M., Di Sabatino, A., Danese, S., & Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) (2026). Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup. Alimentary Pharmacology & Therapeutics, 64(10), 1421-1431. https://doi.org/10.1111/apt.70954

Vancouver

Massironi S, Lenti MV, Lahner E, Galbiati M, Scatena F, Miceli E, et al. Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup. Alimentary Pharmacology & Therapeutics. 2026;64(10):1421-1431. doi:10.1111/apt.70954

BibTeX
@article{Massironi2026,
  author = {Massironi, Sara and Lenti, Marco Vincenzo and Lahner, Edith and Galbiati, Maria and Scatena, Flavia and Miceli, Emanuela and Bella, Chiara Della and Facciotti, Federica and D'Elios, Mario M and Di Sabatino, Antonio and Danese, Silvio and Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO), Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO)},
  title = {Association Between Proton Pump Inhibitor Use and Gastric Neuroendocrine Neoplasms in Autoimmune Gastritis: A Real‐World Propensity Score‐Matched Study From the Autoimmune gastRitis Italian netwOrk Study grOup},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {10},
  pages = {1421--1431},
  doi = {10.1111/apt.70954}
}
Start for free →